home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

75.25 +0.48 (+0.64%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

49 50 Next >

Global Diabetes Care Market Size Expected To Reach $41.71 Billion By 2027

October 25, 2023

EQNX::TICKER_START (OTCPK:CNER),(NYSE:NVO),(NASDAQ:TNDM),(NASDAQ:DXCM),(NASDAQ:LXRX) EQNX::TICKER_END

Via FinancialNewsMedia

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 23, 2023

Via Benzinga

2 Stock-Split Stocks That Could Plunge Up to 89%, According to Select Wall Street Analysts ↗

October 23, 2023

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are two high-flying stock-split stocks a pair of analysts believe will lose their...

Via The Motley Fool

Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years ↗

October 20, 2023

Via Benzinga

Comparing DexCom With Industry Competitors In Health Care Equipment & Supplies Industry ↗

October 18, 2023

Via Benzinga

MarketBeat Week in Review – 10/16 - 10/20

October 21, 2023

All the major indexes moved lower on Friday, making it a near certainty that stocks would post their worst week in a month; the bears are firmly in control

Via MarketBeat

Topics Bonds Economy

10 Health Care Stocks Whale Activity In Today's Session ↗

October 19, 2023

Via Benzinga

The 7 Best Nasdaq Stocks To Buy Now: October 2023 ↗

October 19, 2023

The best Nasdaq stocks go much deeper than the magnificent 7 and offer surprising stability in addition to broad exposure to AI.

Via InvestorPlace

3 Nasdaq-100 Stocks Trading Less Than 10x 2024 Earnings

October 19, 2023

These three Nasdaq-100 stocks can be had for less than 10x 2024 earnings - extra compelling given that Wall Street expects Nasdaq profits will grow next year.

Via MarketBeat

Topics Bonds Economy

Price Over Earnings Overview: DexCom ↗

October 18, 2023

Via Benzinga

Analyst Expectations for DexCom's Future ↗

October 17, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 18, 2023

Via Benzinga

Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday ↗

October 18, 2023

U.S. stocks traded lower, with the Dow Jones falling around 50 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

2 Healthcare Stocks Near Their 52-Week Lows That Could Double in Value ↗

October 18, 2023

These can be excellent investments to buy and hold for years.

Via The Motley Fool

Is the Ozempic-Driven DexCom Selloff Overdone?

October 18, 2023

Has glucose monitor maker DexCom corrected too much on fears of lost sales due to weight loss and diabetes drugs made by Novo Nordisk and Eli Lilly?

Via MarketBeat

Looking Into DexCom's Recent Short Interest ↗

October 17, 2023

Via Benzinga

Why DexCom Stock Rallied on Monday ↗

October 16, 2023

The medical device maker got a little love from Wall Street.

Via The Motley Fool

DexCom Unusual Options Activity ↗

October 13, 2023

Via Benzinga

While growth is established for NASDAQ:DXCM, the stock's valuation remains reasonable. ↗

October 18, 2023

NASDAQ:DXCM is not too expensive for the growth it is showing.

Via Chartmill

3 Stock-Split Stocks With 110% to 696% Upside, According to Select Wall Street Analysts and Pundits ↗

October 18, 2023

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three stock-split stocks select people on Wall Street believe offer...

Via The Motley Fool

Why DexCom Stock Is Rising During Monday's Session ↗

October 16, 2023

DexCom, Inc. (NASDAQ: DXCM) shares are trading higher by 3.75% to $79.05 Thursday afternoon. Leerink Partners initiated coverage on the stock with an Outperform rating and a $110 price target.

Via Benzinga

Why DexCom (DXCM) Stock Hit A New 52-Week Low Today ↗

October 12, 2023

DexCom, Inc. (NASDAQ: DXCM) shares are trading lower by 1.58% to $77.73 Thursday afternoon.

Via Benzinga

A Bull Market Is Coming: 2 Magnificent Stock-Split Growth Stocks That Could Soar 40% and 51%, According to Wall Street ↗

October 08, 2023

Two investor-favorite stock-split stocks still have plenty of room to run.

Via The Motley Fool

Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years ↗

October 02, 2023

Via Benzinga

(DXCM) - Analyzing DexCom's Short Interest ↗

September 29, 2023

Via Benzinga

Analyst Expectations for DexCom's Future ↗

September 29, 2023

Via Benzinga

1 Stock-Split Stock to Buy Hand Over Fist in October and 1 to Avoid ↗

October 04, 2023

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's one historically cheap stock-split stock, as well as another company that carries...

Via The Motley Fool

Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD

October 02, 2023

From DexCom, Inc.

Via Business Wire

Buy this Tech Stock on the Dip in October for 50% Upside? ↗

September 30, 2023

DexCom, Inc. is a connected medical device standout that has posted steadily massive YoY growth as more people in the U.S. and globally suffer from diabetes.

Via Talk Markets

Dexcom Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023 at 4:30 p.m. Eastern Time.

September 29, 2023

From DexCom, Inc.

Via Business Wire

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

49 50 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com